Hangzhou Biotest Biotech Co Ltd Cash Flow Quality Index
Hangzhou Biotest Biotech Co Ltd cash flow quality index. Hangzhou Biotest Biotech Co Ltd (688767) has a Cash Flow Quality Index of 2.88x as of September 2025. Operating cash flow of CN¥28.39 Million exceeds net income of CN¥9.86 Million, indicating high earnings quality where cash backs reported profits. Explore 688767 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Hangzhou Biotest Biotech Co Ltd (2017–2025)
Cash flow quality index of Hangzhou Biotest Biotech Co Ltd from 2017 to 2025. Historical Cash Flow Quality Index for Hangzhou Biotest Biotech Co Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. See 688767 net asset quality score to measure how much of total assets are equity-financed.
Hangzhou Biotest Biotech Co Ltd Cash Flow Quality Index by Year (2017–2025)
Hangzhou Biotest Biotech Co Ltd cash flow quality index by year from 2017 to 2025. Year-by-year earnings quality comparison for Hangzhou Biotest Biotech Co Ltd. For the full cash flow conversion analysis, see Hangzhou Biotest Biotech Co Ltd cash conversion from operations.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.16x | CN¥106.47 Million | CN¥49.25 Million | ▲ +179.8% |
| 2024 | 0.77x | CN¥128.83 Million | CN¥166.78 Million | ▼ -37.3% |
| 2023 | 1.23x | CN¥131.38 Million | CN¥106.61 Million | ▲ +35.6% |
| 2022 | 0.91x | CN¥703.21 Million | CN¥773.58 Million | ▼ -16.3% |
| 2021 | 1.09x | CN¥908.12 Million | CN¥835.76 Million | ▲ +6.0% |
| 2020 | 1.03x | CN¥446.07 Million | CN¥434.97 Million | ▲ +11.6% |
| 2019 | 0.92x | CN¥25.67 Million | CN¥27.94 Million | ▼ -18.2% |
| 2018 | 1.12x | CN¥21.17 Million | CN¥18.85 Million | ▼ -46.7% |
| 2017 | 2.11x | CN¥7.07 Million | CN¥3.36 Million | — |